Tci Wealth Advisors, Inc. Kodiak Sciences Inc. Transaction History

Tci Wealth Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$80.85 - $128.49 $3,961 - $6,296	-49 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$81.97 - $106.94 $4,016 - $5,240	49 New	49 $5,000
Q2 2021 Aug 02, 2021	SELL	$77.2 - $126.54 $2,702 - $4,428	-35 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$110.45 - $164.47 $3,865 - $5,756	35 New	35 $4,000

111

43M

87.8K

7.3K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $114M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.